PCN93 Cost-Effectiveness Analysis of DEB-TACE Compared to Lipiodol-TACE As First LINE Treatment for Unresectable HCC Apre una nuova scheda del browser
(2020)
Inizio contenuto principale del sito
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)